documents: FDA-2022-P-0614-0005

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-P-0614-0005 FDA FDA-2022-P-0614 Interim Response Letter from FDA CDER to Yichang Humanwell Pharmaceuticals LLC Other Letter(s) 2022-10-26T04:00:00Z 2022 10 2022-10-26T04:00:00Z   2022-10-26T12:25:39Z   0 0 090000648545ccbf

Links from other tables